BioAscend

2.2K posts

BioAscend banner
BioAscend

BioAscend

@BioAscend

Bio Ascend is an independent medical education company helping #oncology & hematology health care providers translate innovative science into clinical practice.

100% Virtual Katılım Mayıs 2016
644 Takip Edilen742 Takipçiler
BioAscend
BioAscend@BioAscend·
When data is moving fast, it matters who’s presenting it. #DDHO2026 brings together internationally renowned faculty for expert updates across solid tumors and hematologic malignancies. Join for a day or the full program—virtual, July 23–26. CME credit. 🔗 Register now: loom.ly/I5S0yE0 📋 Agenda: loom.ly/CDvvC9s #CME #MedEd #Oncology
BioAscend tweet media
English
0
0
0
56
BioAscend
BioAscend@BioAscend·
Virtual registration is available for #DDHO2026! Get access to 4 days of fast-paced, clinically relevant updates across solid tumors and hematologic malignancies, including interactive debates, patient-based multidisciplinary panels with ASCO/EHA highlights, and featured “Lecture of the Day” sessions. Perfect for busy clinics and multisite teams. 📅 July 23–26 🔗 Register now: loom.ly/I5S0yE0 📋 Agenda: loom.ly/CDvvC9s #MedEd #CME #Oncology #Hematology #CancerCare
BioAscend tweet media
English
0
1
1
144
BioAscend
BioAscend@BioAscend·
What will you walk away with from #LEAD2026? 🩺 Practice-changing clinical updates across hematology and oncology 🛠️ Hands-on career development workshops 🎙️ Keynote: Dr Jennifer Grandis 🤝 1:1 mentoring sessions 🏆 Award recognition 📅 Sept 18–19, 2026 | Washington, DC Join us: loom.ly/6f6nvIE #LEAD2026 #Hematology #Oncology #WomenInMedicine
BioAscend tweet media
English
0
0
0
40
BioAscend
BioAscend@BioAscend·
🔬 Cutting-edge clinical updates are coming to #LEAD2026! 🎗️ Women’s cancers: Drs Franco & Schlam 🩺 GI cancers: Dr Conces 🩸 NHL & CLL: Drs Stephens & Colton 🫁 Lung cancer: Drs Olazagasti & Scott 🩺 GU cancers: Drs Mittal & Fahey 🩸 MM & Acute Leukemias: Dr Ragon 📅 Sept 18–19 | 📍 Washington, DC Register: loom.ly/6f6nvIE
BioAscend tweet media
English
0
0
0
66
BioAscend
BioAscend@BioAscend·
What will you walk away with from #LEAD2026? 🩺 Practice-changing clinical updates across hematology and oncology 🛠️ Hands-on career development workshops 🎙️ Keynote: Dr Jennifer Grandis 🤝 1:1 mentoring sessions 🏆 Award recognition 📅 Sept 18–19, 2026 | Washington, DC Join us: loom.ly/6f6nvIE #LEAD2026 #Hematology #Oncology #WomenInMedicine
BioAscend tweet media
English
0
0
0
53
BioAscend
BioAscend@BioAscend·
Meet with 1 of these expert faculty for an engaging and informative discussion about the care of patients with low-grade serous ovarian cancer (LGSOC) ✔ Discuss general strategies for treating LGSOC ✔ Hear perspectives regarding the current treatment landscape ✔ Gain insights from experts Request your meeting today: loom.ly/lVAbld
BioAscend tweet media
English
0
0
0
59
BioAscend
BioAscend@BioAscend·
🚨 Don’t Miss This at #AATS2026 🚨 Join us for a 1-hour program examining how pathologic complete response (pCR) is defined, assessed, and operationalized in clinical trials for resectable #NSCLC. 📆 May 4, 2026 at 12:00 PM CT Sign Up Now: loom.ly/EwBh-jg
BioAscend tweet media
English
0
0
0
36
BioAscend
BioAscend@BioAscend·
Expert faculty are diving into the clinical and operational sides of pCR—its definition, assessment, and role in trials and how it shapes adjuvant treatment decisions alongside other prognostic biomarkers. Sign up now to stay ahead in the field. 🔗 loom.ly/EwBh-jg #AATS2026 #NSCLC
BioAscend tweet media
English
0
0
1
43
BioAscend
BioAscend@BioAscend·
✨Last Chance to Join Harvesting Knowledge: A Summit on #MultipleMyeloma 📍 Napa, CA 🗓️ April 25, 2026 🔗‍️ loom.ly/Ziv2EZ8 Register today for #MMSummit26—a focused, clinically-driven summit designed to equip health care professionals with the latest evidence‑based insights and practical strategies for managing multiple myeloma across the full continuum of care. #Oncology #MM #CME
BioAscend tweet media
English
0
0
0
65
BioAscend
BioAscend@BioAscend·
Why attend #MMSummit2026 in Napa on April 25? Because the MM treatment landscape is evolving fast—this program is designed to address your most pressing clinical concerns Join expert faculty to: • Align treatment strategies across SMM, NDMM, and RRMM • Optimize sequencing—what to start, when to switch, and how to personalize • Apply real-world insights from recently-approved therapies, including bispecific antibodies • Strengthen AE mitigation strategies to sustain outcomes 📍 Napa, CA | April 25 🔗‍️Register Today: loom.ly/Ziv2EZ8 #MultipleMyeloma #Oncology #Hematology
BioAscend tweet media
English
0
0
0
55
BioAscend
BioAscend@BioAscend·
How does pCR in clinical trials translate to real-world surgical practice? Join us Monday, May 2 | 12–1PM CT | #AATS2026 📋 Agenda highlights: 🔹The Evolving Role of pCR in Clinical Trials 🔹Protocols for Assessing pCR 🔹Prognostic Biomarkers: Escalate or De-Escalate? 🔹Panel: Multidisciplinary Roles of the Pathologist & Surgeon Register: loom.ly/EwBh-jg #NSCLC #AATS2026
BioAscend tweet media
English
0
0
1
72
BioAscend retweetledi
AATS
AATS@AATSHQ·
SPONSORED: Join us for a 1-hour program examining how pathologic complete response (pCR) is defined, assessed, and operationalized in clinical trials for resectable #NSCLC. #AATS2026 May 4, 2026 at 12:00 PM CT Sign Up Now: loom.ly/EwBh-jg
AATS tweet media
English
1
4
10
892
BioAscend
BioAscend@BioAscend·
Join us for a 1-hour program examining how pathologic complete response (pCR) is defined, assessed, and operationalized in clinical trials for resectable #NSCLC. 📆 May 4, 2026 at 12:00 PM CT 📍 #AATS2026 Sign Up Now: loom.ly/EwBh-jg
BioAscend tweet media
English
0
0
0
46